XML 74 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares) 8      
Numerator for earnings (loss) per share calculation:        
Net income (loss) attributable to CVS Health $ (3,416) $ 1,598 $ 1,847 $ 6,604
Denominator for earnings (loss) per share calculation:        
Weighted average shares, basic (in shares) 1,315 1,321 1,313 1,318
Weighted average diluted shares outstanding (in shares) 1,315 1,329 1,324 1,326
Earnings (loss) per share:        
Earnings (loss) per share, basic (in dollars per share) $ (2.60) $ 1.21 $ 1.41 $ 5.01
Earnings (loss) per share, diluted (in dollars per share) $ (2.60) $ 1.20 $ 1.40 $ 4.98
Restricted stock units and performance stock units        
Denominator for earnings (loss) per share calculation:        
Effect of dilutive securities (in shares) 0 4 6 5
Stock options and stock appreciation rights        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from computation of EPS (in shares) 4 8 4 8
Denominator for earnings (loss) per share calculation:        
Effect of dilutive securities (in shares) 0 4 5 3